ANGELINA CASK NEUROLOGICAL RESEARCH FOUNDATION
ACNRF has partnered with the UK Cask Research Foundation to raise enough money to fund a promising research project that aims to cure CASK gene disorders by activating a backup copy of CASK in girls.
In the brain of every female with a CASK gene mutation, there are silenced copies of the healthy CASK gene. The project is proposing to “turn on” these silenced genes. The genes will then be able to create the CASK protein.
This will, theoretically, result in a brain which, initially having just half of the CASK protein needed to function properly, will have much more. This should have a dramatic impact on the prognosis of the disease since the brain will now have enough of the CASK protein needed to function properly.
The project will involve two parallel research streams:
CASK aims to follow in the footsteps of two more common Xlinked genetic disorders: MECP2 and Rett syndrome. Xreactivation has successfully been done (in mice models) for the two genes that cause these neurological disorders. UC Davis is eager to have the opportunity to try their technique on the CASK gene – a gene that displays all the markers of being a successful candidate for this novel therapeutic.
The UC Davis MIND Institute located in California is a collaborative international research center, committed to the awareness, understanding, prevention, and treatment of the challenges associated with neurodevelopmental disabilities and rare x linked disorders.
PLEASE VIEW THIS VIDEO
Copyright © 2020 Angelina Cask Neurological Research Foundation - All Rights Reserved.
Angelina Cask Neurological Research Foundation Ltd (A.B.N. 11643569153) is a registered Australian Charity (It is registered with the Australian Charities and Not for Profit Commission - which is an Australian Government body)
Liability Limited by a Scheme Approved Under Professional Standards Legislation
Powered by the ACNRF Platform